BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12593523)

  • 1. Comparison of the efficacy and safety of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler in paediatric patients with moderate to severe exacerbation of asthma.
    Bisca N; Cernatescu I; Dragomir D; Iacomi A; Mirceau M; Orascanu D
    Respir Med; 2003 Feb; 97 Suppl B():S15-20. PubMed ID: 12593523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy and safety of high doses of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler in steroid-dependent adults with moderate to severe asthma.
    Grzelewska-Rzymowska I; Kroczynska-Bednarek J; Zarkovic J
    Respir Med; 2003 Feb; 97 Suppl B():S21-6. PubMed ID: 12593524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of two different dosages of beclometasone dipropionate suspension for nebulization versus a standard dose of beclometasone dipropionate via a metered-dose inhaler on bronchoprovocation testing in adults with asthma.
    Bousquet J; Meziane H; Chanez P; Mueser M; Umile A
    Respir Med; 2003 Feb; 97 Suppl B():S11-4. PubMed ID: 12593522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the bioavailability and systemic effects of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler after single-dose administration in healthy male volunteers.
    Poli G; Acerbi D
    Respir Med; 2003 Feb; 97 Suppl B():S5-9. PubMed ID: 12593521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of beclometasone dipropionate and fluticasone propionate suspensions for nebulization in adult patients with persistent asthma.
    Terzano C; Ricci A; Burinschi V; Nekam K; Lahovsky J
    Respir Med; 2003 Feb; 97 Suppl B():S35-40. PubMed ID: 12593526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of triamcinolone acetonide MDI with a built-in tube extender and beclomethasone dipropionate MDI in adult asthmatics.
    Berkowitz R; Rachelefsky G; Harris AG; Chen R
    Chest; 1998 Sep; 114(3):757-65. PubMed ID: 9743163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and acceptance of beclomethasone dipropionate administered via a new dry powder Inhaler or a standard CFC metered-dose inhaler in asthma patients.
    Kunkel G; Schäper C; Noga O; Schläfke S; Lemmnitz G; Köhler S
    Respiration; 2003; 70(4):399-406. PubMed ID: 14512676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of double-strength beclomethasone dipropionate (84 microg) MDI with beclomethasone dipropionate (42 microg) MDI in the treatment of asthma.
    Nathan RA; Nolop KB; Cuss FM; Lorber RR
    Chest; 1997 Jul; 112(1):34-9. PubMed ID: 9228354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of nebulized beclometasone dipropionate and budesonide in severe persistent childhood asthma.
    Delacourt C; Dutau G; Lefrançois G; Clerson P;
    Respir Med; 2003 Feb; 97 Suppl B():S27-33. PubMed ID: 12593525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma.
    Terzano C; Allegra L; Barkai L; Cremonesi G
    Eur Rev Med Pharmacol Sci; 2001; 5(1):17-24. PubMed ID: 11860218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
    J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new beclomethasone dipropionate multidose powder inhaler in the treatment of bronchial asthma.
    Nieminen MM; Vidgren P; Kokkarinen J; Laasonen K; Liippo K; Lindqvist A; Paananen M; Poukkula A; Ruotsalainen E; Salomaa E; Sovijärvi A; Söderblom T; Silvasti M; Vidgren M; Laitinen LA
    Respiration; 1998; 65(4):275-81. PubMed ID: 9730793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between sodium cromoglycate (MDI: metered-dose inhaler) and beclomethasone dipropionate (MDI) in treatment of adult patients with mild to moderate bronchial asthma. A double-blind, double-dummy randomized, parallel-group study.
    Faurschou P; Bing J; Edman G; Engel AM
    Allergy; 1994 Sep; 49(8):659-63. PubMed ID: 7653745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler.
    Dhillon S; Keating GM
    Drugs; 2006; 66(11):1475-83; discussion 1484-5. PubMed ID: 16906779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids.
    Paggiaro P; Corradi M; Latorre M; Raptis H; Muraro A; Gessner C; Siergiejko Z; Scuri M; Petruzzelli S
    BMC Pulm Med; 2016 Dec; 16(1):180. PubMed ID: 27938358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative clinical study of inhaled beclomethasone dipropionate and triamcinolone acetonide in persistent asthma.
    Bronsky E; Korenblat P; Harris AG; Chen R
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):295-302. PubMed ID: 9564977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
    Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
    Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate.
    Nicolini G; Cremonesi G; Melani AS
    Pulm Pharmacol Ther; 2010 Jun; 23(3):145-55. PubMed ID: 19961948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
    Vondra V; Sladek K; Kotasová J; Terl M; Rossetti A; Cantini L
    Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.